COVID-19 Community Treatment Program

There are a range of anti-SARS-COV-2 monoclonal antibodies (MAB) and antiviral medications that have been provisionally approved by the Therapeutic Goods Administration. These medications are for the treatment of patients in the early phase of infection with COVID-19 who are at risk of progression to severe disease and within a window of five days from onset of infections.

Local access to these medications will be through NSW Health facilities, Aboriginal Medical Services and aged care facilities.

The medications covered in this model of care currently include:

  • Sotrovimab
  • Casirivimab and Imdevimam
  • Molnupiravir
  • Nirmatrelvir plus Ritonavir.

Further information can be obtained from the CEC’s website as well as the ACI’s Model of Care summary.

The criteria for treatment with the above medications include:

  • commencement within five days of symptom onset (or seven days for Casirivimab plus Imdevimab) AND
  • no oxygen requirement due to COVID-19 infection AND
  • reduced immunity to COVID-19 by being…AND
    • not fully vaccinated against COVID-19
    • unvaccinated against COVID-19
    • overdue for a booster vaccination against COVID-19 (as per ATAGI guidelines)
    • immunocompromised as per ATAGI guidelines (irrespective of vaccine status and age)
  • medication-specific risk factors outlined in Table 1 for adults or Table 2 for adolescents (see ACI’s Model of Care summary pages three and five.

GPs are able to access the above listed COIVD-19 oral treatment medications through their local Network hospital.

For the Coffs Clinical Network (Coffs Harbour region, Bellingen, Macksville and Dorrigo catchment areas), medications will be provided through the Coffs Harbour Health Campus.

For the Hastings Macleay Clinical Network (Port Macquarie region, Kempsey and Wauchope catchment areas), medications will be provided through the Port Macquarie Base Hospital.

GPs are required to complete a prescription declaration form and email through to the relevant local Network hospital for processing. Please ensure that the patient’s contact details are correct so that we are able to arrange supply of these medications within a timely manner.

Prescription and Declaration – Oral antiviral medicines for COVID-19 [GPs] (

COVID Community Oral Treatments IPU Form

Patients are able to access the medications listed above through their GP or local emergency departments (on advice of their GPs).

View the factsheet for Paxlovid and Lagevrio for more information.


Top of page